Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Version label updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no other substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:16:02.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-06T14:47:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as a range of new chemical compounds and diseases, while removing several previous terms related to diseases and pharmacological agents.
    Difference
    6%
    Check dated 2025-08-30T11:32:30.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.7%
    Check dated 2025-08-23T07:51:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.8%
    Check dated 2025-08-16T04:37:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:54:22.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.